ZLAB: Zai Lab Limited - ADR Company Profile & Statistics

Zai Lab Limited - ADR Profile

About

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

Info & Links

CEO

Samantha (Ying) Du

Headquarters

4560 JINKE ROAD,BLDG. 1, 4F, PUDONG
SHANGHAI, F4 201210, CHINA

Auditor

KPMG LLP

Share holders

Employees

1,869

Zai Lab Limited - ADR Statistics

Valuation Measures

Market Capitalization²

3.63B

Enterprise Value

2.97B

Enterprise Value/EBITDA(ttm)

-12.47

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

8.34

Price to Book(mrq)

4.48

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

62.43%

Operating Margin(ttm)

-49.68%

Profit Margin(ttm)

-49.54%

Return on Equity(ttm)

-27.32%

Return on Invested Capital(ttm)

-27.07%

Return on Assets(ttm)

-18.85%

Income Statement

Revenue(ttm)

427.80M

Revenue Per Share(ttm)

3.89

Gross Profit(ttm)

266.92M

EBITDA(ttm)³

-238.36M

Net Income Available to Common(ttm)

-212.52M

Diluted EPS(ttm)

-2.04

Share Statistics

Beta (5Y Monthly)

1.04

52-Week Change

57.71%

S&P 500 52-Week Change

17.09%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

109.96M

Dividend Yield

0.00%

Float⁴

106.22M

% Held by Insiders

4.96%

% Held by Institutions

41.65%

Balance Sheet

Total Cash(mrq)

832.27M

Total Cash Per Share(mrq)

7.57

Total Debt(mrq)

174.51M

Total Debt/Equity(mrq)

22.04%

Current Ratio(mrq)

3.12%

Quick Ratio(mrq)

2.93%

Book Value Per Share(mrq)

7.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.85

Free Cash Flow(ytd)

-97.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ZLAB

Zai Lab Limited - ADR